How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Bioprinting Market
- By Technology: Inkjet Bioprinting, Extrusion Bioprinting, Laser-Assisted Bioprinting, Stereolithography Bioprinting, Microvalve Bioprinting
- By Bio-ink Type: Hydrogel-based Bio-inks, Cell-laden Bio-inks, Decellularized Extracellular Matrix (dECM) Bio-inks, Synthetic Polymer Bio-inks, Composite Bio-inks
- By Application: Tissue Engineering and Regeneration, Drug Discovery and Development, Cancer Research, Organ Transplantation, Cosmetic and Skin Care Testing
- By End User: Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Hospitals and Clinics, Contract Research Organizations (CROs), Cosmetic Industry
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Inkjet Bioprinting leads By Technology at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 281 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.170 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.178 →
Full report · locked preview
Everything inside the Bioprinting Market report
A complete, evidence-based study - 11 chapters and 118 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Technology 5
Bio-ink Type 5
Application 5
End User 5
Companies profiled
Organovo Holdings Inc.
CELLINK (a BICO company)
3D Systems Corporation
EnvisionTEC (a Desktop Metal company)
RegenHU Ltd.
Allevi (acquired by 3D Systems)
Aspect Biosystems
Poietis
InvivoSciences
Readily3D
TeVido BioDevices
Prellis Biologics
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Organovo Holdings Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →CELLINK (a BICO company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →3D Systems Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →EnvisionTEC (a Desktop Metal company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →RegenHU Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Allevi (acquired by 3D Systems)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Aspect Biosystems
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Poietis
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →InvivoSciences
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Readily3D
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →TeVido BioDevices
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Prellis Biologics
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Cyfuse Biomedical K.K.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Axol Bioscience
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →BioBots (now part of Allevi)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →
Global · 2025–2033
$4,016M by 2033 · 6.2% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Inkjet Bioprinting59.6
- Extrusion Bioprinting11.2
- Laser-Assisted Bioprinting11.6
- Stereolithography Bioprinting9.1
- Microvalve Bioprinting8.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$821.2M → $1,415M · 7.0%
Europe$572.3M → $996.7M · 7.2%
Asia Pacific$522.6M → $867.4M · 6.5%
Latin America$323.5M → $504.1M · 5.7%
Middle East and Africa$248.8M → $451.8M · 7.7%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.122026
6.132027
6.132028
6.162029
6.182030
6.182031
6.202032
6.202033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Organovo Holdings Inc.16.4
- CELLINK (a BICO company)13.4
- 3D Systems Corporation14.9
- EnvisionTEC (a Desktop Metal company)5.4
- RegenHU Ltd.11.2
- Allevi (acquired by 3D Systems)10.7
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Technology26.6%
Bio-ink Type22.5%
Application21.3%
End User29.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.4
- Europe23.5
- Asia Pacific20.5
- Latin America11.9
- Middle East and Africa10.7
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Organovo Holdings Inc. | 97 | 82 | 88 | 74 | 93 | 77 | 85 |
| CELLINK (a BICO company) | 84 | 80 | 83 | 81 | 68 | 69 | 78 |
| 3D Systems Corporation | 86 | 64 | 74 | 77 | 75 | 67 | 74 |
| EnvisionTEC (a Desktop Metal company) | 63 | 72 | 64 | 60 | 76 | 60 | 66 |
| RegenHU Ltd. | 61 | 54 | 72 | 64 | 62 | 57 | 62 |
| Allevi (acquired by 3D Systems) | 70 | 60 | 49 | 59 | 66 | 49 | 59 |
| Aspect Biosystems | 59 | 52 | 55 | 65 | 41 | 60 | 55 |
| Poietis | 60 | 60 | 46 | 39 | 53 | 56 | 52 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Organovo Holdings Inc.
- CELLINK (a BICO company)
- 3D Systems Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Organovo Holdings Inc. | ✓ | ✓ | ✓ | ◐ | ◐ | ✓ |
| CELLINK (a BICO company) | ✓ | ◐ | ◐ | ✓ | ◐ | − |
| 3D Systems Corporation | ✓ | ◐ | ◐ | ◐ | ✓ | ◐ |
| EnvisionTEC (a Desktop Metal company) | ✓ | ◐ | ◐ | − | ✓ | ◐ |
| RegenHU Ltd. | − | − | ✓ | − | − | ◐ |
| Allevi (acquired by 3D Systems) | ◐ | ◐ | ◐ | ◐ | ◐ | − |
| Aspect Biosystems | ◐ | − | − | ◐ | − | ◐ |
| Poietis | ◐ | ◐ | − | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Organovo Holdings Inc.85
2CELLINK (a BICO company)78
33D Systems Corporation74
4EnvisionTEC (a Desktop Metal company)66
5RegenHU Ltd.62
6Allevi (acquired by 3D Systems)59
7Aspect Biosystems55
8Poietis52
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Organovo Holdings Inc.CELLINK (a BICO company)
Challenger1
Strong scale, closing on the leaders.
3D Systems Corporation
Contender3
Focused players with pockets of strength.
EnvisionTEC (a Desktop Metal company)RegenHU Ltd.Allevi (acquired by 3D Systems)
Niche2
Specialists in a single segment or region.
Aspect BiosystemsPoietis
Go-to-market strategy
Land Technology in North America, then scale across Bioprinting Market — a $523M beachhead inside a $8.52B market.
Beachhead (SOM)$523Mobtainable near-term
Serviceable (SAM)$2.99Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Inkjet Bioprinting
Best fit — highest urgency & budget in Technology.
Economic buyer80 fit
Extrusion Bioprinting
Strong fit — clear ROI and a fast path to value.
End user65 fit
Laser-Assisted Bioprinting
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Technology in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Bio-ink Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel30%
Digital / self-serve21%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Technology leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Bioprinting Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified41%
Sales qualified24%
Evaluation12%
Closed-won8%
$8.7KCAC
$51KLTV
5.8:1LTV : CAC
< 4 moCAC payback
Investment thesis
Bioprinting Market is a resilient opportunity — $7.69B by 2033, compounding at 4.7%.
TAM · 2025$5.32Btoday
TAM · 2033$7.69Bforecast
CAGR4.7%2027–2033
Cumulative$58.0Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$7.69BTotal addressable market
SAM$2.86BServiceable available market
SOM$489MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.7% CAGR
Demand compounds through 2033, outpacing GDP across Technology.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Technology moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$7.69BLarge & growingTAM by 2033 at 4.7% CAGR
$2.86BServiceable nowreachable with today’s model
$489MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$6.00BBear3.1% CAGR
$7.69BBase4.7% CAGR
$9.84BBull6.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Bio-ink Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Bioprinting Market — a $9.68B market by 2033. Plan: grow share from 10.1% to 16.2%.
Market size · 2033$9.68Btotal addressable
Market CAGR10.3%2027–2033
Target share16.2%from 10.1% today
Revenue ambition$1.57Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 10.1% | 16.2% | On track |
| Revenue | $1.08B | $1.57B | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 31.5% | 42.3% | On track |
| Customer retention | 87.2% | 94.9% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Technology
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Bio-ink Type capability
A defensible second engine — invest in Bio-ink Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Technology share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Bio-ink Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $162M capacity & capability investment
- Greenlight bolt-on M&A in Bio-ink Type
- Authorise North America expansion plan
- Fund R&D program for Technology leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskBehind
- Regulatory / policy changeBehind
- Execution & talentBehind
Sales deck · value proposition
Win the Bioprinting Market conversation — a $3.89B market you can size, segment and defend in minutes.
Market size · 2033$3.89Btotal opportunity
Growth9.9%CAGR to 2033
Addressable buyers1,424+accounts in scope
Typical ROI4.8×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Technology
Goal Grow share in Technology
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.8×return on cost, year one
< 4 mopayback period
$72K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Organovo Holdings Inc.CELLINK (a BICO company)3D Systems CorporationEnvisionTEC (a Desktop Metal company)RegenHU Ltd.Allevi (acquired by 3D Systems)Aspect BiosystemsPoietis+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Bioprinting Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Bioprinting Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Bioprocess Bags and Containers Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportBioprocess Container Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportBioprocessing Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportBioprosthetic Heart Valves Market
Market size, share, segmentation and regional forecast.
$722M market · 2025 base year
View reportBiopsy Cannula Market
Market size, share, segmentation and regional forecast.
$960M market · 2025 base year
View reportBiopsy Cassettes Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportBiopsy Forcep Market
Market size, share, segmentation and regional forecast.
$736M market · 2025 base year
View reportBiopsy Instrumens Market
Market size, share, segmentation and regional forecast.
$496M market · 2025 base year
View reportBiopsy Needle Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportBiopsy Punches Market
Market size, share, segmentation and regional forecast.
$327M market · 2025 base year
View reportBio-Rad Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportBioreactors & Fermenters Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.